History

2011 Biocompatibles International plc aquired by BTG plc
2009 Biocompatibles acquires MoleMateTM and the SIAscopy patents
2008 Biocompatibles acquires BrachySciences
2006 The DC Bead® is launched
2005 Biocompatibles acquires CellMed
2002 The Eye Care Division is sold to the Cooper Companies Inc and The Cardiovascular Stent business is sold to Abbott Laboratories. £100m of capital is returned to shareholders
1998 The BiodivYsio stent is launched
1995 Biocompatibles is floated on the London Stock Exchange (LSE:BII)
1994 ProClear contact lens is launched
1984 Professor Dennis Chapman, CChem FRSC, FRS (1927-1999) establishes